Matrine in association with FD-2 stimulates F508del-cystic fibrosis transmembrane conductance regulator activity in the presence of corrector VX809

Cystic fibrosis is caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, and the predominant mutation is termed Phe508del (F508del). Therapy for F508del-CFTR patients is based on the use of Orkambi(®), a combination of VX809 and VX770. However, though Orkambi le...

Descripción completa

Detalles Bibliográficos
Autores principales: Marengo, Barbara, Speciale, Andrea, Senatore, Lisa, Garibaldi, Silvano, Musumeci, Francesca, Nieddu, Erika, Pollarolo, Benedetta, Pronzato, Maria Adelaide, Schenone, Silvia, Mazzei, Mauro, Domenicotti, Cinzia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779973/
https://www.ncbi.nlm.nih.gov/pubmed/29039559
http://dx.doi.org/10.3892/mmr.2017.7736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779973/
https://www.ncbi.nlm.nih.gov/pubmed/29039559
http://dx.doi.org/10.3892/mmr.2017.7736

Ejemplares similares